Title |
Extended peginterferon plus ribavirin treatment for 72 weeks versus standard peginterferon plus ribavirin treatment for 48 weeks in chronic hepatitis C genotype 1 infected slow‐responder adult patients
|
---|---|
Published in |
Cochrane database of systematic reviews, September 2012
|
DOI | 10.1002/14651858.cd008516.pub2 |
Pubmed ID | |
Authors |
Lior H Katz, Hadar Goldvaser, Anat Gafter‐Gvili, Ran Tur‐Kaspa |
Abstract |
The standard length of peginterferon plus ribavirin treatment for chronic hepatitis C virus (HCV) genotype 1 infected patients is 48 weeks. However, the number of patients demonstrating a sustained virological response is not high. In order to improve sustained virological response, extending the length of the treatment period has been suggested. |
Mendeley readers
The data shown below were compiled from readership statistics for 98 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 98 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 12 | 12% |
Student > Bachelor | 10 | 10% |
Student > Postgraduate | 8 | 8% |
Student > Ph. D. Student | 8 | 8% |
Researcher | 6 | 6% |
Other | 18 | 18% |
Unknown | 36 | 37% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 31 | 32% |
Nursing and Health Professions | 9 | 9% |
Psychology | 6 | 6% |
Pharmacology, Toxicology and Pharmaceutical Science | 3 | 3% |
Agricultural and Biological Sciences | 3 | 3% |
Other | 8 | 8% |
Unknown | 38 | 39% |